| 1. |
. Tauscher RG, Bison HS, Simon SS, et al. Intracranial posterior ischemic optic neuropathy and ophthalmic artery occlusion[J/OL]. J Neuroophthalmol, 2022, 42(2): e476-e478[2022-06-01]. https://pubmed.ncbi.nlm.nih.gov/34310459/. DOI: 10.1097/WNO.0000000000001313.
|
| 2. |
Hayreh SS. Management of ischemic optic neuropathies[J]. Indian J Ophthalmol, 2011, 59(2): 123-136. DOI: 10.4103/0301-4738.77024.
|
| 3. |
Ko SB, Lee K. Acute optic-nerve infarction in carotid dissection[J]. N Engl J Med, 2010, 363(8): 765. DOI: 10.1056/NEJMicm0909070.
|
| 4. |
. Tavakoli M, Sotoudeh H, Rezaei A, et al. Optic nerve infarction in a patient with coronavirus disease 2019[J/OL]. Neuroophthalmol, 2022, 42(1): e347-e348[2022-03-01]. https://pubmed.ncbi.nlm.nih.gov/33560703/. DOI: 10.1097/WNO.0000000000001232.
|
| 5. |
. Chaulk AL, Do TH, Supsupin EP, et al. A unique radiologic case of optic nerve infarction in a patient with mucormycosis[J/OL]. J Neuroophthalmol, 2021, 41(3): e354-e356[2021-09-01]. https://pubmed.ncbi.nlm.nih.gov/33449489/. DOI: 10.1097/WNO.0000000000001179.
|
| 6. |
. Kang JJ, Lee ES, Lee HJ, et al. Case report: bilateral posterior ischemic optic neuropathy in a patient with atrial fibrillation and multifocal embolic stroke[J/OL]. Front Neurol, 2022, 13: 988825[2022-12-02]. https://pubmed.ncbi.nlm.nih.gov/36530620/. DOI: 10.3389/fneur.2022.988825.
|
| 7. |
. Huang HT, Tung TH, Lin M, et al. Characterizing spatiotemporal progression and prediction of infarct lesion volumes in experimental acute ischemia using quantitative perfusion and diffusion imaging[J/OL]. Appl Radiat Isot, 2021, 168: 109522[2020-11-19]. https://pubmed.ncbi.nlm.nih.gov/33290998/. DOI: 10.1016/j.apradiso.2020.109522.
|
| 8. |
Augstburger E, Héron E, Abanou A, et al. Acute ischemic optic nerve disease: pathophysiology, clinical features and management[J]. J Fr Ophtalmol, 2020, 43(3): 256-270. DOI: 10.1016/j.jfo.2019.12.002.
|
| 9. |
Nagaraja N, Forder JR, Warach S, et al. Reversible diffusion-weighted imaging lesions in acute ischemic stroke: a systematic review[J]. Neurology, 2020, 94(13): 571-587. DOI: 10.1212/WNL.0000000000009173.
|
| 10. |
Luchesa Smith A, Sudarsan N, Hemingway C, et al. Diagnosis and management of multiple sclerosis and other relapsing demyelinating disease in childhood[J]. Arch Dis Child, 2022, 107(3): 216-222. DOI: 10.1136/archdischild-2021-321911.
|
| 11. |
Winter A, Chwalisz B. MRI characteristics of NMO, MOG and MS related pptic neuritis[J]. Semin Ophthalmol, 2020, 35(7-8): 333-342. DOI: 10.1080/08820538.2020.1866027.
|
| 12. |
Bennett JL, Costello F, Chen JJ, et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment[J]. Lancet Neurol, 2023, 22(1): 89-100. DOI: 10.1016/S1474-4422(22)00187-9.
|
| 13. |
Bender B, Heine C, Danz S, et al. Diffusion restriction of the optic nerve in patients with acute visual deficit[J]. J Magn Reson Imaging, 2014, 40(2): 334-340. DOI: 10.1002/jmri.24367.
|
| 14. |
Kuhlmann T, Moccia M, Coetzee T, et al. Multiple sclerosis progression: time for a new mechanism driven framework[J]. Lancet Neurol, 2023, 22(1): 78-88. DOI: 10.1016/S1474-4422(22)00289-7.
|
1/5
